None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Male or female subjects aged 19 to 40 years Individuals with facial acne lesions corresponding to IGA grades 2–3 Subjects who voluntarily agree to participate after receiving a full explanation of the study Subjects willing to comply with restrictions on the use of other skincare products during the test period
Exclusion criteria
Exclusion criteria: Subjects with severe acne or significant dermatologic disease other than acne Use of acne treatments (topical or systemic), steroids, or retinoids within 2 weeks prior to study initiation Subjects who received dermatological procedures such as laser, peeling, or acne extraction within the last 4 weeks Known history of allergy or hypersensitivity to the test product or its ingredients Pregnant or breastfeeding women Individuals deemed unsuitable for study participation by the investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in IGA (Investigator’s Global Assessment) grade | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluation of skin barrier function using TEWL measured by Tewameter;Change in ASI (Acne Severity Index) score;Change in inflammatory acne lesion count;Change in non-inflammatory acne lesion count;Assessment of facial sebum secretion using Visioscan and Sebufix (Immediate Sebum Secretion Rate);Assessment of facial skin hydration using Corneometer | — |
Countries
Korea, Republic of
Contacts
SKINMED